focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Robust trading at Cello Group

Tue, 14th May 2013 08:33

Marketing firm Cello said strong trading has continued so far this year, driven by its health division and a recovery at its consumer unit, and expects half year results higher than last year.The group said a strong pipeline of work secured at the end of 2012 and continued healthy new business activity in 2013 had underpinned progress.The US continues to see strong activity levels and Cello Health plans to open a new office in Chicago shortly.Looking ahead, it said it is confident that business wins combined with good visibility in the order book in both the Health and Consumer businesses, will deliver a half year result in excess of the prior year. The Board also remains confident that full year expectations will be met.Cello said its cash position is considerably stronger than expected, reflecting excellent working capital performance. In a separate statement Cello said it has named Stephen Highley as Corporate Development Director.Cello's shares surged 6.0% to 53.00p at 09:30 in London.CJ

Related Shares

More News
7 Aug 2020 20:11

IN BRIEF: Court Order Sanctions Arsenal's Cello Acquisition

IN BRIEF: Court Order Sanctions Arsenal's Cello Acquisition

4 Aug 2020 09:05

IN BRIEF: Cello Health Gets Shareholder Approval For Arsenal Takeover

IN BRIEF: Cello Health Gets Shareholder Approval For Arsenal Takeover

1 Jul 2020 12:10

Arsenal Capital makes £179m offer for Cello Health

(Sharecast News) - Cello Health said on Wednesday it had agreed to a takeover from private venture company Arsenal Capital Partners, valuing the compa...

13 May 2020 16:18

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

8 Apr 2020 12:53

Wednesday broker round-up

(Sharecast News) - Travis Perkins: JP Morgan downgrades to underweight with a target price of 920p.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.